COVID-19 vaccine
-
December 20, 2022
Reminder: COVID-19 bivalent boosters available through Occupational Health Clinic
-
December 16, 2022
Bivalent booster vaccine effective in preventing COVID-19 hospitalization in older adults
The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over. -
November 4, 2022
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. -
September 13, 2022
COVID-19 bivalent vaccine boosters available for employees of VUMC and VU, as well as patients
-
August 24, 2022
COVID antibody research conducted at VUMC lands national award
A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine. -
July 20, 2022
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. -
July 6, 2022
Study shows two vaccine doses for mothers eases COVID complications for infants
Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.